Trending Now
Hepion Pharmaceuticals Inc (NASDAQ:HEPA) Releases Early Stage Data For CRV431’s Research...
Hepion Pharmaceuticals Inc (NASDAQ:HEPA) recently released its initial clinical study evaluating its developmental anti-fibrotic drug CRV431’s ability to combat COVID-19.
The company revealed in its...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Ecommerce Stocks Could be Recession Proof as Household Spending Holds Up...
The ecommerce space is a prime example of a new path toward recession-proof non-cyclicality in a world where household savings are robust...
MAKE IT MODERN
LATEST REVIEWS
Akebia Therapeutics Inc (NASDAQ:AKBA) Files NDA With The US FDA For...
Akebia Therapeutics Inc (NASDAQ:AKBA) filed an NDA (New Drug Application) for its Vadadustat with the US FDA to treat adult patients suffering from anemia...
MAKE IT MODERN
PERFORMANCE TRAINING
B2Digital Inc (OTCMKTS:BTDG) Sets Up for Big Things Ahead
B2Digital Inc (OTCMKTS:BTDG), an emerging force on the OTC billing itself as the premier development league for the UFC and top pro MMA sports,...
Bitcoin Stocks Primed as Inflation Concerns Build (BKKT, ISWH, RIOT, MARA, MSTR, HIVE, COIN)
The concept of a “safe haven” is critical for investors to understand when they consider cross asset capital flows. One key philosophical...
DS-100 is the Fifth Drug Application Under FDA Review Of Eton Pharmaceuticals Inc. (NASDAQ:ETON),...
Through the introduction of innovative medicines, Eton Pharmaceuticals Inc. (NASDAQ:ETON) has taken up the responsibility of advancing the healthcare sector. This is in addition...
Sorrento Therapeutics Inc (NASDAQ: SRNE) Receives NMPA Authorization of Phase 1 Study of ...
Sorrento Therapeutics Inc (NASDAQ: SRNE) has revealed the NMPA clearance of a first phase study of the oral main viral protease inhibitor, STI-1558, in...
Borealis Foods Inc. (BRLS) Soars 77%: Analyzing the Recent Surge and Company Insights
Borealis Foods Inc. (NASDAQ: BRLS) has captured significant market attention with a notable surge, closing the session at $7.11, up 77.75%. However,...
MAKE IT MODERN
